ClassID:

170609

G01N2333/91057 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes; Transferases (2.); Acyltransferases (2.3); Acyltransferases other than aminoacyltransferases (general) (2.3.1) with definite EC number (2.3.1.-)

Sub-classes:
Recent Application in this class:
#1
20250277784
2025-09-04

EXPRESSION SYSTEMS FOR THE ALPHA6BETA4 NICOTINIC ACETYLCHOLINE RECEPTOR AND METHODS OF USE THEREOF

#2
20250264460
2025-08-21

METHOD OF MEASURING LEVEL OF IMMUNE SUPPRESSION

#3
20250251393
2025-08-07

APOB:CFAS CONTENT TO AID IN THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASES

#4
20250179589
2025-06-05

SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER

#5
20250129404
2025-04-24

RAPID, COLORIMETRIC ASSAY TO DETECT ACETYLTRANSFERASE ACTIVITY IN BIOLOGICAL SAMPLES

#6
20250014677
2025-01-09

JOINT PROFILING OF GENETIC VARIANTS, DNA METHYLATION, GPC METHYLTRANSFERASE FOOTPRINTS, 3D GENOME AND TRANSCRIPTOME

#7
20250011719
2025-01-09

NEW METHOD FOR IMPROVING QUALITY OF PLATELETS

#8
20240425865
2024-12-26

METHODS FOR TREATING CELLULAR INFLAMMATION INDUCED BY AFB1

#9
20240331862
2024-10-03

SCREENING METHOD AND INDENDITIES OF BIOMARKERS FOR DIFFERENTIAL DIAGNOSIS OF PARKINSONISM AND/OR COGNITIVE IMPAIRMENT

#10
20240230656
2024-07-11

Predicting Prognosis and Treatment Response of Breast Cancer Patients Using Expression and Cellular Localization of N-Myristoyltransferase

#11
20240229056
2024-07-11

TOXIN-FREE ALOE AND METHODS OF MAKING SAME

#12
20240125768
2024-04-18

METHODS FOR MODULATING A SRC-1 CONDENSATE

#13
20230374603
2023-11-23

SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER

#14
20230285009
2023-09-14

N-myristoyltransferase 2 Overexpression in Peripheral Blood and Peripheral Blood Mononuclear Cells is a Marker for Colorectal Cancer

#15
20230273214
2023-08-31

Predicting prognosis and treatment response of breast cancer patients using expression and cellular localization of N-myristoyltransferase

#16
20220196660
2022-06-23

Methods for Modulation of Acetyltransferase Activity and Applications Thereof Including Treatments

#17
20220195398
2022-06-23

ABHD5 AND PARTIAL HDAC4 FRAGMENTS AND VARIANTS AS A THERAPEUTIC APPROACH FOR THE TREATMENT OF CARDIOVASCULAR DISEASES

#18
20220107328
2022-04-07

METHODS OF TREATING LIVER DISEASES

#19
20220034898
2022-02-03

DETERMINING FETAL LUNG MATURITY USING A MATERNAL SAMPLE

#20
20220034891
2022-02-03

USE OF ACYL COENZYME A: CHOLESTEROL ACYLTRANSFERASE-1 IN DIAGNOSIS AND TREATMENT OF LIVER CANCER

#21
20220034887
2022-02-03

METHODS OF DETECTION AND TREATMENT FOR CARDIOVASCULAR DISEASE AND FOOT WOUNDS

#22
20220009915
2022-01-13

CHEMICAL PROBES AND METHODS OF USE THEREOF

#23
20210318312
2021-10-14

Sirtuin 4 (SIRT4) lipoamidase activity and uses thereof

#24
20200319209
2020-10-08

Modulation of gene expression in a human bioreactor

#25
20200158732
2020-05-21

GHRELIN O-ACYLTRANSFERASE (GOAT) AND USES THEREOF

#26
20190105025
2019-04-11

N-myristoyltransferase 2 Overexpression in Peripheral Blood and Peripheral Blood Mononuclear Cells is a Marker for Colorectal Cancer

#27
20190094225
2019-03-28

SIRT4 lipoamidase activity and uses thereof

#28
20190093168
2019-03-28

N-myristoyltransferase (NMT)1, NMT2 and methionine aminopeptidase 2 overexpression in peripheral blood and peripheral blood mononuclear cells is a marker for adenomatous polyps and early detection of colorectal cancer

#29
20190010555
2019-01-10

SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER

#30
20180321225
2018-11-08

Methods of detection and treatment for cardiovascular disease and foot wounds

#31
20180259515
2018-09-13

Methods for molecular classification of fatty liver by high-throughput protein post-translational modifications

#32
20180258407
2018-09-13

ABHD5 and partial HDAC4 fragments and variants as a therapeutic approach for the treatment of cardiovascular diseases

#33
20180179596
2018-06-28

HISTONE MODIFICATION AGENTS FOR CANCER TREATMENT

#34
20180051263
2018-02-22

Materials and methods for characterizing and using a 3-ketoacyl-acyl carrier protein (ACP) synthase III (KASIII) for production of bi-functional fatty acids

#35
20170362633
2017-12-21

NRAS related cancer therapy

#36
20170335337
2017-11-23

Regulatory sequences for modulating transgene expression in plants

#37
20170067899
2017-03-09

Method for predicting responsiveness to cancer treatment using p300-inhibiting compound

#38
20160216268
2016-07-28

SRM/MRM assay for the fatty acid synthase protein

#39
20160209412
2016-07-21

MSIA-SRM ASSAY FOR BIOMARKER ANALYSIS

#40
20160108376
2016-04-21

ABHD5 and partial HDAC4 fragments and variants as a therapeutic approach for the treatment of cardiovascular diseases

#41
20160090576
2016-03-31

Materials and methods for characterizing and using KASIII for production of bi-functional fatty acids

#42
20160054322
2016-02-25

Homogenous thermal shift ligand binding assay

#43
20150368692
2015-12-24

ANALYSIS OF THE ESTERIFICATION LEVEL OF CEREBROSTEROL AS A TOOL FOR DIAGNOSIS AND/OR PROGNOSIS OF NEURODEGENERATION

#44
20150337387
2015-11-26

N-MYRISTOYLTRANSFERASE 2 OVEREXPRESSION IN PERIPHERAL BLOOD AND PERIPHERAL BLOOD MONONUCLEAR CELLS IS A MARKER FOR COLORECTAL CANCER

#45
20150329836
2015-11-19

Specific internalization of nanoparticles into protein cages

#46
20150275309
2015-10-01

SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER

#47
20150184177
2015-07-02

REGULATORY SEQUENCES FOR MODULATING TRANSGENE EXPRESSION IN PLANTS

#48
20150050665
2015-02-19

PREDICTIVE BIOMARKERS FOR BREAST CANCER

#49
20140099650
2014-04-10

Monoclonal antibodies and detection methods for phosphinothricin-N-acetyl-transferase enzyme

#50
20130345267
2013-12-26

Methods and compositions for modulating P300/CBP activity

#51
20130095483
2013-04-18

PREDICTIVE BIOMARKERS FOR BREAST CANCER

#52
20130040327
2013-02-14

Methods for identifying allosteric and other novel acyl-coenzyme A:cholesterol acyltransferase inhibitors

#53
20130011870
2013-01-10

Method For Assaying Diseases Characterized By Dyslipidemia

#54
20120165218
2012-06-28

Method and assay for determining FAS expression

#55
20110150773
2011-06-23

MODULATORS OF ACETYL-COENZYME A ACYLTRANSFERASE 1 OR 2 IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA

#56
20110150772
2011-06-23

MODULATORS OF CARNITINE OCTANOYLTRANSFERASE IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA

#57
20100292302
2010-11-18

INDUCTION OF APOPTOSIS AND INHIBITION OF CELL PROLIFERATION THROUGH MODULATION OF CARNITINE PALMITOYLTRANSFERASE 1C ACTIVITY

#58
20100216853
2010-08-26

Methods and compositions for modulating P300/CBP activity

#59
20100178280
2010-07-15

USE OF SIRT7 FOR TREATING AGE-RELATED DISEASES

#60
20100173982
2010-07-08

Method for the asymmetric synthesis of beta-lactone compounds

#61
20100152277
2010-06-17

DIACYLGLYCEROL ACYLTRANSFERASE ASSAY

#62
20100068731
2010-03-18

Use of N-myristoyltransferase on non-tumor tissue for cancer diagnosis

#63
20100047246
2010-02-25

Methods and Compositions for Treating Vascular Disease

#64
20090208990
2009-08-20

Human protein acyl transferases and methods of uses therefor

#65
20080070257
2008-03-20

High throughput screening assay for histone modifying enzyme modulators

#66
20070048853
2007-03-01

Carnitine palmitoyltransferase II crystals

#67
20060258620
2006-11-16

Method for the asymmetric synthesis of beta-lactone compounds

#68
20060040884
2006-02-23

Antisense oligonucleotides directed to genes regulated by trapoxin-induced HDAC inhibition

#69
20060035221
2006-02-16

Use of the glycine n-acyl transferase (gnat) for the diagnosis and therapy of inflammatory diseases and sepsis

#70
20050170437
2005-08-04

Methods and compositions relating to modulating amyloid precursor protein cleavage

#71
20050158811
2005-07-21

Human protein acyl transferases and methods of uses therefor

#72
20050147970
2005-07-07

Breast cancer associated polypeptide

#73
14656120
2019-12-03

Determination of LCAT